Continuous subcutaneous infusion of compound oxycodone for the relief of dyspnea in terminally ill cancer patients: a retrospective study
American Journal of Hospice and Palliative Medicine, 06/21/2012
Kawabata M et al. – These results suggest that continuous subcutaneous administration of oxycodone could be one of the reasonable alternatives in the management of dyspnea in patients with terminally ill cancer.



